As of January 23, 2025, TransMedics Group (TMDX) has a market cap of $2.08 billion USD. According to our data, TransMedics Group is ranked No.4081 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $2.08 B |
-0.61%
|
Dec 31, 2024 | $2.09 B |
-21.01%
|
Dec 29, 2023 | $2.65 B |
27.88%
|
Dec 30, 2022 | $2.07 B |
222.13%
|
Dec 31, 2021 | $0.64 B |
-3.72%
|
Dec 31, 2020 | $0.67 B |
4.68%
|
Dec 31, 2019 | $0.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Medtronic
MDT
|
$114.47 B |
-0.001 M
|
Ireland
|
Edwards Lifesciences
EW
|
$40.65 B |
-0.001 M
|
USA
|
Abbott Laboratories
ABT
|
$213.69 B |
-0.001 M
|
USA
|
Boston Scientific
BSX
|
$149.80 B |
-0.007 M
|
USA
|
Stryker Corporation
SYK
|
$150.00 B |
0.002 M
|
USA
|
Zimmer Biomet
ZBH
|
$22.10 B |
0.001 M
|
USA
|
Baxter
BAX
|
$16.25 B |
-0.000 M
|
USA
|
Intuitive Surgical
ISRG
|
$216.79 B |
0.003 M
|
USA
|
Getinge
GETI-B.ST
|
$4.96 B |
0.394 B
|
Sweden
|
LivaNova
LIVN
|
$2.64 B |
-0.000 M
|
UK
|
Penumbra
PEN
|
$10.59 B |
0.000 M
|
USA
|
Teleflex
TFX
|
$8.40 B |
0.000 M
|
USA
|
Market Cap | = | TMDX Stock Price | * | TMDX Shares Outstanding |
= | $61.97 | * | 33.56 M | |
= | $2.08 B |